« Back
Home /
TAS-102 (Trifluridine/Tipiracil HCl)

TAS-102 (Trifluridine/Tipiracil HCl)

Item no.	V13524-5mg
Manufacturer	InvivoChem LLC
CASRN	733030-01-8
Amount	5 mg
Quantity options	100 mg 10 mg 250 mg 25 mg 500 mg 50 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	733030-01-8
Available
Description	InvivoChem Cat #:V13524CAS #:733030-01-8Purity >=98% Description: TAS-102 (a mixture of Trifluridine and tipiracil hydrochloride in a 1:0.5 molar ratio) is a combination drug under investigation for treating metastatic colorectal cancer. It is an orally bioavailable combination drug composed of trifluridine (TFT), an antineoplastic thymidine-based nucleoside analog, and Tipiracil hydrochloride (TTP), a potent thymidine phosphorylase inhibitor, in a molar ratio of 1 : 0.5. References: 1. Uboha N, et al. TAS-102: a novel antimetabolite for the 21st century. Future Oncol. 2016 Jan; 12(2):153-63.; 2. Nukatsuka M, et al. Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, with irinotecan hydrochloride on human colorectal and gastric cancer xenografts. Anticancer Res. 2015 Mar; 35(3):1437-45. Related CAS #: 733030-01-8 (183204-72-0 (Tipiracil HCl) 70-00-8 (Trifluridine)

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Delivery expected until 7/3/2025

Express Delivery: Save 16 days

Compare

Add to wishlist

Recommend by mail